New strategic plan for ‘future of nursing science’ released

The National Institute of Nursing Research (NINR) has released its first new strategic plan in five years, focusing on the implementation of precision medicine and greater use of data science in clinical trials.

“In developing this strategic plan, we have focused on the areas of science in which the needs are greatest, and for which we believe NINR-supported science can have the largest impact,” said NINR Director Patricia A. Grady in her introduction to the plan. “The plan reflects not only the long-standing focus areas of nursing science, but also areas in which nurse scientists can use their expertise in clinical research and their understanding of the relationship between behavior and biology to further expand the reach and impact of nursing science in the larger community.”

Four areas where research efforts should be rescued are identified in the plan: symptom science, wellness, self-management, and end-of-life and palliative care. 

NINR said the plan was crafted in part thanks to responses to its innovative questions initiative from researchers, medical organizations and the general public.

“It is important to remember, however, that this plan is intended to be a flexible, living document. As new science and new opportunities emerge, and as new health challenges arise, NINR will regularly seek to reassess and adapt its research strategies to meet these needs and opportunities,” the plan said.

The full strategic plan is available here

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”